Sustained release compositions of 4-aminopyridine

The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.

Saved in:
Bibliographic Details
Main Authors Cobb, Jr., Joseph E, Way, Susan L, D'Souza, Rohini, Gold, Thomas B
Format Patent
LanguageEnglish
Published 09.07.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
Bibliography:Application Number: US202117374285